Last $0.59 HKD
Change Today -0.01 / -1.67%
Volume 716.2K
401 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

wanjia group holdings ltd (401) Snapshot

Open
$0.60
Previous Close
$0.60
Day High
$0.61
Day Low
$0.58
52 Week High
10/11/13 - $1.25
52 Week Low
01/8/14 - $0.51
Market Cap
382.6M
Average Volume 10 Days
451.6K
EPS TTM
$0.08
Shares Outstanding
648.4M
EX-Date
--
P/E TM
7.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for WANJIA GROUP HOLDINGS LTD (401)

Related News

No related news articles were found.

wanjia group holdings ltd (401) Related Businessweek News

No Related Businessweek News Found

wanjia group holdings ltd (401) Details

Wanjia Group Holdings Limited operates in the wholesale and distribution of pharmaceutical and healthcare products in the Fujian Province in the People’s Republic of China through its subsidiaries. It trades prescription medicines and over-the-counter medicines, including branded and generic Western and Chinese medicines, as well as healthcare products, medical devices, and other products to public hospitals and healthcare institutions, as well as companies operating pharmaceutical retail chain stores, independent pharmacies, out-patient departments of community hospitals, healthcare service stations, and clinics; and to distributor customers. The company also offers retail of pharmaceutical products through retail pharmacies under the ‘Huihao Sihai’ brand name. As of September 20, 2013, it had 100 retail pharmacies in Fujian Province. The company was founded in 2004 and is headquartered in Fuzhou, China. Wanjia Group Holdings Limited operates as a subsidiary of Greatly Wealth Global Group Limited.

1,176 Employees
Last Reported Date: 06/27/14
Founded in 2004

wanjia group holdings ltd (401) Top Compensated Officers

Vice Chairman, Executive Director and Member ...
Total Annual Compensation: $105.0K
Compensation as of Fiscal Year 2014.

wanjia group holdings ltd (401) Key Developments

Wanjia Group Holdings Limited Reports Audited Consolidated Earnings Results for the Year Ended March 31, 2014

Wanjia Group Holdings Limited reported audited consolidated earnings results for the year ended March 31, 2014. For the year, the company has posted turnover of HKD 2,096,455,000 against HKD 1,885,369,000 a year ago. Profit from operations was HKD 80,196,000 against HKD 64,767,000 a year ago. Profit before taxation was HKD 74,181,000 against HKD 60,677,000 a year ago. Profit for the year was HKD 49,068,000 against HKD 41,905,000 a year ago. Profit for the period attributable to owners of the company was HKD 48,920,000 or 7.54 Hong Kong cents basic and diluted per share against HKD 41,763,000 or 6.44 cents basic and diluted per share a year ago. Net cash generated from operating activities was HKD 8,942,000 compared to net cash generated used in operating activities of HKD 46,885,000 a year ago. Purchase of property, plant and equipment was HKD 5,263,000 against HKD 2,216,000 a year ago.

Wanjia Group Holdings Limited to Report Fiscal Year 2014 Results on Jun 25, 2014

Wanjia Group Holdings Limited announced that they will report fiscal year 2014 results on Jun 25, 2014

Wanjia Group Holdings Limited, Board Meeting, Jun 25, 2014

Wanjia Group Holdings Limited, Board Meeting, Jun 25, 2014., at 14:30 China Standard Time. Agenda: To approve the publication of the final results of the Company and its subsidiaries for the year ended March 31, 2014; and to consider the payment of a final dividend, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
401:HK $0.59 HKD -0.01

401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Nepstar Chain Drugstore Ltd $2.32 USD -0.01
Huadong Medicine Co Ltd CNY54.19 CNY -3.11
Jointown Pharmaceutical Group Co Ltd CNY14.15 CNY -0.08
Nanjing Pharmaceutical Co Ltd CNY6.02 CNY +0.01
Shanghai Pharmaceuticals Holding Co Ltd CNY12.79 CNY -0.03
View Industry Companies
 

Industry Analysis

401

Industry Average

Valuation 401 Industry Range
Price/Earnings 8.0x
Price/Sales 0.2x
Price/Book 0.4x
Price/Cash Flow 8.0x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANJIA GROUP HOLDINGS LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.